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    The radioprotective effects of vitamin C and famotidine were investigated using the micronucleus test for 
anticlastogenic and cell proliferation activity. Various doses of vitamin C and famotidine were administered 
intraperitoneally 2 h before 2Gy gamma irradiation to NMRI adult male mice. Frequency of micronuclei in 
1000 PCEs (MnPCEs) were scored for each sample. Cell proliferation ratio (PCE/PCE+NCE) was also 
calculated. Data were statistically evaluated using one-way ANOVA and Tukey’s HSD test. The results 
indicated that gamma irradiation alone caused a significant increase in the MnPCEs and reduced the cell 
proliferation ratio. Administration of various doses of famotidine and vitamin C before gamma irradiation 
reduced MnPCEs and therefore clastogenic effects of radiation. Famotidine didn’t change cell proliferation 
compared to the irradiation group but vitamin C significantly improved and increased cell proliferation to 
the control group’s level. The dose reduction factor (DRF) calculated, shows a DRF=2 for famotidine and a 
DRF=1.7 for vitamin C which is indicative of a high radioprotective property of these compounds. The way 
in which these compounds reduced the clastogenic effects of radiation might be via antioxidant property and 
free radical scavenging mechanism. 
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INTRODUCTION 
    Exposure to ionizing radiation results in a 
deposition of energy in tissues and production of 
free radicals. Free radicals are highly reactive 
chemicals and can initiate a chain of events in the 
cell which will eventually lead to injury and even 
cell death [1]. If free radicals being neutral and 
inactive before reaction to critical molecules, an 
effective radiation protection exerts in the cells [1, 
2]. Due to water radiolysis, the most abundant 
intracellular compounds, various types of free 
radicals are generated such as hydroxyl radicals 
(OH˚), hydrogen radicals (H˚) and solvated 
electrons [e- (aq)]. In the presence of oxygen, 
reactive oxygen species (ROS) such as superoxide 
anion (O2) and hydrogen peroxide (H2O2) are also 
formed, leading to induction of more DNA 
damage and radiation cytotoxicity in the cells [1, 
3, 4]. The OH˚ is generally considered the most 
damaging of the oxygen-based free radicals and it 
is believed to account for an estimated 50% of the 
total damages induced by free radical mechanisms 
[5]. Famotidine is a histamine H2-receptor 
antagonist usually used for peptic ulcer treatment 
[6]. It is demonstrated that famotidine, in addition 
to being a good inhibitor of histamine stimulated 
gastric acid secretion, is a highly powerful 
hydroxyl-radical scavenger that can provide 
protection against the harmful effects of ionizing 
radiation [7].  
Researchers have shown radioprotective effects of 
famotidine against radiation induced lipid 
peroxidation [8], DNA damage [9], apoptosis [10] 
and radiation induced lethality [11]. Vitamin C is 
the major water soluble antioxidant in the body 
and is an effective free radical and reactive 
oxygen species scavenger that can donate 
electrons to the chain reactions initiated by free  
 




radicals and stop oxidative stress conditions in the 
body [12, 13]. These properties have persuaded 
many researchers to study the radioprotective 
effects of vitamin C leading to obtain acceptable 
results.  
Administration of vitamin C before gamma 
irradiation prevented chromosomal damage and 
micronuclei formation in bone marrow cells, 
peripheral blood lymphocytes and leukocytes [14, 
15], induction of apoptosis in peripheral blood 
leukocytes [10] and radiation-induced lethality 
[16]. Vitamin C led to repair of double strand break 
(DSB) and improved cell survival [17] and had a 
radioprotective effect against mutagenesis in cells 
[18]. In this study, we intend to test and compare 
radioprotective effects of famotidine and vitamin 
C, which are potent free radical scavengers, non 
toxic, abundant, accessible and affordable, in mice 
bone marrow cells using micronuclei test. 
Micronuclei are acentric chromosomal fragments 
or lagging chromosomes that can’t migrate to 
daughter cells, so remain in the mother cell 
cytoplasm and are visible as a small nucleus. The 
micronucleus test developed by Schmid and his 
colleagues in 1975 [19], is a reliable, sensitive and 
effective alternative method for the evaluation of 
clastogenic and cytotoxic effects of physical and 
chemical agents in vitro and in vivo [20, 21]. 
 
MATERIALS AND METHODS 
Animals 
    Six-week old male NMRI mice were purchased 
from the Pasteur Institute (Karaj, Iran). They were 
housed in cages for one week, provided with 
proper light, temperature and moisture, and fed 
with standard mouse pellet and water ad libitum. 
Seven-week old mice weighting 25±5 gr were used 
to experiments.  
 Drug treatment 
    Famotidine powder was provided from the 
Chemidarou Pharmaceutical Co, (Tehran, Iran) and 
vitamin C provided from the Osvah 
Pharmaceutical Co. (Tehran, Iran). Various doses 
of famotidine (5, 10 and 20 mg/kg) and vitamin C 
(50, 100 and 200 mg/kg) were dissolved in distilled 
water and injected to mice intraperitoneally, 2h 
before irradiation.  
Irradiation 
    A 60-Co radiotherapy unit (Theratron II, 780 C, 
Canada) was used for gamma irradiation. The mice 
were grouped into 5, kept in a plexiglass box, and 
irradiated with 2Gy gamma rays. The source to 
sample distance (SSD) was 80 cm and the dose rate 
was 50 cGy/min. The mice were irradiated, some 
in the presence and some in the absence of 
different doses of famotidine or vitamin C.  
The micronucleus assay 
    The mouse bone marrow micronucleus test was 
carried out according to the method described by 
Schmid [19]. The mice were killed by cervical 
dislocation 24 hours after irradiation. Similarly, 
control groups were also sampled 24 hours after 
injection. Their femoral bone marrow was flushed 
out by means of fetal calf serum, and a cell 
suspension was duly prepared. The suspension was 
centrifuged for 7 minutes at 1000 rpm. After 
centrifuging, the supernatant was removed and 
cells were resuspended in the remaining serum and 
a smear was prepared, fixed with methanol and 
stained by the May Grunwald-Giemsa method. In 
this method of staining, polychromatic 
erythrocytes (PCEs) are stained blue-violet, while 
normochromatic erythrocytes (NCEs) are stained 
yellow-orange. 
Microscopic and statistical analysis                 
An Y100 Nikon microscope with ×100 objective 
lens was used for scoring the cells.  A total of 1000 
PCEs was scored for the presence of micronuclei 
for each sample. In order to study the cytotoxic 
effects of gamma rays on the proliferation of the 
bone marrow cells, the ratio of PCEs/PCEs+NCEs 
was calculated. The significance of any intergroup 
differences in the number of micronucleated PCEs 
as well as the ratio of PCEs/PCEs+NCEs was 
statistically evaluated by the one-way ANOVA and 
Tukey’s HSD test. 
 
RESULTS 
     The results are shown in Table 1. Statistical 
analysis showed that the groups that had received 
maximum doses of famotidine (20 mg/kg) and 
vitamin C (200 mg/kg) alone, showed no 
significant differences in MnPCEs and cell 
proliferation ratio in comparison with the control 
group (P>0.05).  
Therefore, lower doses of these compounds also do 
not have any clastogenic or cytotoxic effects. As 
shown in Table 1, the gamma radiation caused a 
significant increase in the frequency of MnPCEs in 
comparison with the control group (P<0.0001).  
 




Table 1. The frequency of MnPCEs and the ratio of PCEs/PCEs+NCEs in bone marrow erythrocytes exposed to 2 Gy gamma 














*Values indicate the mean values obtained from five mice. A total number of 5000 PCEs were scored for each sample. Errors 
are standard errors of mean values.                                                                                                                                 
** Doses of drugs are in mg/kg body weight injected i.p. 2 h before irradiation. Fam and VitC are the  abbreviations of 
famotidine and vitamin C, respectively.
 
Injection of various doses of famotidine and 
vitamin C, before radiation exposure showed a 
significant reduction in the MnPCEs in both 
famotidine and vitamin C groups (P<0.0001). In 
famotidine groups, there was no significant 
difference in the frequency of MnPCEs between 5 
and 20 mg/kg (P>0.05), so, dose of 5 mg/kg could 
considered as optimal dose. In vitamin C groups, 
there was a significant difference in the frequency 
of MnPCEs between 50 and 200 mg/kg (P<0.05) 
but the dose of 100 mg/kg did not have any 
difference with 50 and 200 mg/kg, therefore the 
dose of 100 mg/kg could considered as optimal 
dose. Table 2 illustrates the DRF calculated for 
various doses of famotidine and vitamin C.  
The statistical analysis performed for the cell 
proliferation ratio (PCEs/PCEs+NCEs) showed a 
significant difference between the control and 
gamma-irradiated group (p<0.0001) (Table 1). 
 
Table 2. DRF calculated for the frequency of MnPCEs 
induced by gamma rays in the presence of famotidine or 
vitamin C. 
*Values indicate the mean values of frequency of 
MnPCEs in treatment groups over the mean values of 
frequency of MnPCEs in gamma irradiated group. Errors 
are standard errors of mean values. 
Such a difference was also seen between the 
gamma-irradiated group and various doses of 
vitamin C groups (p<0.0001); so that vitamin C 
increased cell proliferation ratio to control 
group’s level. Comparing the different doses of 
vitamin C showed no significant difference 
between groups. In addition, there was no 
difference between the gamma-irradiated group 
and various doses of famotidine (P>0.05) 
indicating that famotidine could not reduce 
radiation-induced cytotoxicity. In this case, 




     Ionizing radiation induces several damages 
to DNA as the most critical molecule in the 
cell. Among them, double strand break (DSB) 
is the most important damage and produces 
chromosomal aberrations and micronuclei [22]. 
The MN Test is a reliable and effective method 
for the evaluation of clastogenic effects of 
physical and chemical agents in vitro and in 
vivo [14,15].The present study showed a 
remarkable increase in the number of MnPCEs 
and decrease in the cell proliferation ratio for 
the dose of 2Gy gamma radiation compared to 
control groups. These findings are consistent 
with previous findings of many other 
investigators who have shown that gamma ray 
is a potent inducer of MN in bone marrow 
erythrocytes [23-25]. Selected doses of 
famotidine (without any clastogenic and 
Treatment MnPCEs/1000PCEs PCEs/PCEs+NCEs 
Control 4.8 ± 0.66* 0.44 ± 0.01 
Fam 20** 4.8 ± 0.73 0.45 ± 0.005 
VitC 200 3.2 ± 0.86 0.44 ± 0.004 
Gamma rays ( 2 Gy) 97.2 ± 5.39 0.31± 0.004 
Fam 5 + 2 Gy 46.4 ± 2.48 0.33 ± 0.007 
Fam 10 + 2 Gy 57.2 ± 2.83 0.33 ± 0.004 
Fam 20 + 2 Gy 43.4 ± 2.76 0.32 ± 0.004 
VitC 50 + 2 Gy 69.2 ± 1.24 0.43 ± 0.003 
VitC 100 + 2 Gy 59.6 ± 3.88 0.42 ± 0.001 







5 2.09±0.24*  
10 1.7± 0.17  
20 2.23± 0.17  
50  1.4± 0.05 
100  1.63±0.24 
200  1.82± 0.2 
 




cytotoxic effects) reduced the frequency of 
MnPCEs. Calculated DRF was 2. These results 
are consistent with results obtained by other 
researchers that shown radioprotective effects 
of famotidine against induction of micronuclei 
in vitro and in vivo [26,27] and other family 
members of H2 histamine antagonists such as 
cimetidine [28]. In one study, non toxic dose of 
famotidine (2μg) was injected directly into 
mouse testis and DRF=2 was obtained [29]. It 
have demonstrated that histamine H2-receptor 
antagonists such as famotidine, in addition to 
inhibition of histamine stimulated gastric acid 
secretion, are also highly powerful OH˚, HOCl 
and NH2Cl scavengers [7,30]. Hydroxyl radical 
is the most destructive water radiolysis radical. 
Among histamine H2-receptor antagonists, 
famotidine has the highest reaction rate 







This high value is attributed to 3 sulfur atoms in 
the structure of famotidine and is much higher 
than for the well-known hydroxyl-radical 
scavengers such as mannitol and glucose [30]. 
However, famotidine was unable to reduce 
radiation-induced cytotoxicity in bone marrow 
cells. This observation is consistent with 
finding of other researches. Du et al. reported 
that histamine H2-receptor antagonists inhibit 
hemopoietic reconstruction of bone marrow 
after sublethal gamma ray irradiation. 
Therefore, it is probable that famotidine is 
unable to help the bone marrow cell 
reconstruction after gamma irradiation [31]. 
Pre-treatment of mice with different doses of 
vitamin C, 2h before irradiation resulted in a 
significant reduction in the number of MnPCEs. 
Calculated DRF was 1.7. Harapanhaly and 
colleagues obtained DRF=1.7 with counting of 
nucleated cells of tibia after treatment of mice 
with vitamin C and whole body irradiation [32]. 
Injection of non-toxic dose (1.5μg) of vitamin C 
directly into mice testis, protected 





I with DRF= 2.63 
[33,34].  
The most important protection mechanism of 
vitamin C is free radical and reactive oxygen 
species scavenging before interacting with 
critical macromolecules such as DNA [14,15].  
However, other mechanisms of protection have 
been proposed to vitamin C. Vitamin C can 
react directly with DNA molecule, leading to 
induction of more condensation in DNA 
structure and thus may protect against the 
incidence of DSB [35]. Vitamin C abrogates 
pro-apoptosis gene expression and increases 
antiapoptosis gene expression therefore, 
modulates apoptosis in bone marrow cells [36]. 
In addition, vitamin C has a direct role in the 
proliferation and differentiation of bone marrow 
cells [37,38].  
The observed effect of vitamin C in increasing 
of cell proliferation ratio in the present study 
can be attributed to these mechanisms. In this 
study, famotidine was more effective in 
reducing clastogenic effects of gamma rays 
compared to vitamin C. This effect may be 














), yet vitamin C is 
effective than famotidine in reducing cytotoxic 
effect of gamma radiation.  
Radioprotective agents used in radiotherapy 
patients, military personnel, radiation workers 
and people in nuclear accidents should meet 
several criteria such as: (i) offer a good 
protection against acute and chronic radiation 
damage (DRF>1.5). (ii) can be administrated 
easily (oral) and have the ability to be rapidly 
absorbed and distributed throughout of the body 
(iii) have no significant toxicity or side effects 
in the body (iv) be chemically stable (v) be 
widely available and cost-effective [27].  
Famotidine and vitamin C show a good 
radiation protection.  
This two compounds can be administrated 
orally. They are not toxic and have no side 
effects and are accessible and cost- effective. 
These features make them suitable for use as 
chemical radioprotectors for different exposure 
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